CD105
CD105, also known as endoglin (gene symbol ENG), is a homodimeric transmembrane glycoprotein of the vascular endothelium. It acts as a TGF-beta coreceptor and plays an important role in regulating angiogenesis. Browse Assay Genie's current range of CD105 research reagents below, or read on for the biology behind the target.
CD105 is a major glycoprotein of the vascular endothelium and is required for the normal structure and integrity of adult vasculature. It regulates the migration of vascular endothelial cells and is needed for normal extraembryonic angiogenesis and embryonic heart development. It may also regulate endothelial cell shape changes in response to blood flow, which drive vascular remodelling and the establishment of normal vascular morphology, and may contribute to the binding of endothelial cells to integrins and other RGD receptors.
Mechanistically, CD105 is a component of the transforming growth factor beta receptor complex and binds the TGF-beta1 and TGF-beta3 peptides with high affinity. As a TGF-beta coreceptor it participates in the TGF-beta/BMP signalling cascade that leads to activation of SMAD transcription factors. It is required for GDF2/BMP9 signalling through SMAD1 in endothelial cells and modulates TGFB1 signalling through SMAD3. The protein is a homodimeric transmembrane glycoprotein located at the cell membrane, and alternatively spliced transcript variants encoding different isoforms have been reported for the ENG gene.
The gene symbol is ENG, and the protein is also referred to as END, HHT1, ORW and ORW1. The previous name, Osler-Rendu-Weber syndrome 1, reflects its disease link: mutations in the CD105 gene cause hereditary hemorrhagic telangiectasia, an autosomal dominant multisystemic vascular dysplasia. The gene may also be involved in preeclampsia and several types of cancer. The mouse ortholog is Eng.
CD105 regulates endothelial cell migration and is required for normal angiogenesis, making it a central protein for studying vascular development and remodelling.
As a TGF-beta coreceptor needed for BMP9 signalling through SMAD1 and modulation of SMAD3 signalling, it is used to dissect SMAD pathway control.
Mutations in the gene cause hereditary hemorrhagic telangiectasia, an autosomal dominant vascular dysplasia, so CD105 is a key subject in HHT1 studies.
The gene may be involved in preeclampsia and several types of cancer, prompting investigation of CD105 in these disease contexts.
CD105 is a vascular endothelium glycoprotein that regulates angiogenesis and endothelial cell migration. It acts as a TGF-beta coreceptor, supporting TGF-beta/BMP signalling to SMAD transcription factors, including BMP9 signalling through SMAD1 and modulation of TGFB1 signalling through SMAD3.
CD105 is the CD designation for endoglin, encoded by the ENG gene. Aliases include END, HHT1, ORW and ORW1, and a previous name was Osler-Rendu-Weber syndrome 1. Alternatively spliced transcript variants encoding different isoforms have been described.
Mutations in the CD105 gene cause hereditary hemorrhagic telangiectasia type 1, and the gene may be involved in preeclampsia and several cancers. The mouse ortholog is Eng; check the datasheet of any product for its validated reactivity.
Ligands, SMAD transcription factors and other components of the TGF-beta/BMP pathway that interact with CD105.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P17813; product specifications from Assay Genie datasheets.